Conditions and Ketamine Troches
Condition-specific resources covering depression, chronic and neuropathic pain, anxiety, PTSD, OCD, addiction, and related clinical contexts.
Intent match
These articles explain condition-specific evidence and questions for clinicians without promising outcomes.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.
Featured
3 articles
Ketamine Troches for Social Anxiety Disorder: What the Evidence Says
Social anxiety disorder affects millions and often resists standard treatments. Learn how ketamine troches may help through NMDA modulation, neuroplasticity, and fear extinction — and what the research shows.
Ketamine Troches for Neuropathic Pain: Mechanism, Evidence, and Practical Use
Neuropathic pain often resists standard painkillers. How ketamine troches may help via NMDA receptor blockade, what the research shows, and dosing guidance.
Ketamine Troches for Migraine: What the Evidence Shows
Sublingual ketamine troches for migraine and chronic headache: typical dose, abortive vs preventive use, evidence to date, talking to your prescriber.
Ketamine Troches for Social Anxiety Disorder: What the Evidence Says
Social anxiety disorder affects millions and often resists standard treatments. Learn how ketamine troches may help through NMDA modulation, neuroplasticity, and fear extinction — and what the research shows.
Ketamine Troches for Neuropathic Pain: Mechanism, Evidence, and Practical Use
Neuropathic pain often resists standard painkillers. How ketamine troches may help via NMDA receptor blockade, what the research shows, and dosing guidance.
Ketamine Troches for Migraine: What the Evidence Shows
Sublingual ketamine troches for migraine and chronic headache: typical dose, abortive vs preventive use, evidence to date, talking to your prescriber.
Ketamine in Palliative and End-of-Life Care
Ketamine serves dual roles in end-of-life care: managing refractory pain and addressing existential distress and depression. Learn about protocols, evidence, and compassionate use considerations.
Ketamine Troches and Suicidal Ideation
Ketamine produces rapid antisuicidal effects within hours, distinct from its antidepressant effects. Learn about the evidence, safety protocols, and appropriate use for suicidal ideation.
Ketamine for Substance Use Disorders: Emerging Research
Emerging research explores ketamine for alcohol and cocaine use disorders. Learn about the evidence, proposed mechanisms, significant cautions, and the complex risk-benefit picture.
Ketamine Troches and Bipolar Disorder: Risks and Considerations
Ketamine can help bipolar depression but carries significant risks of triggering mania or mixed states. Learn the special considerations, monitoring requirements, and protocols for bipolar patients.
Ketamine Troches for Fibromyalgia
Fibromyalgia responds to ketamine's central sensitization modulation. Learn about low-dose troche protocols, pain modulation mechanisms, and clinical outcomes for fibromyalgia patients.
Ketamine Troches for OCD: Emerging Research
Ketamine shows early promise for treatment-resistant OCD through glutamate modulation. Review the emerging evidence, glutamate hypothesis, case reports, and what patients should know.
Ketamine Troches for Chronic Pain
Ketamine is a powerful analgesic with particular benefits for neuropathic pain, CRPS, and fibromyalgia. Learn how troches are used for pain management, the evidence base, and dosing protocols.
Ketamine Troches for PTSD
Ketamine shows emerging evidence for PTSD treatment through trauma memory reconsolidation disruption and fear circuit modulation. Learn about mechanisms, protocols, and special considerations.
Ketamine Troches for Anxiety Disorders
How sublingual ketamine troches address generalized anxiety, social anxiety, and treatment-resistant anxiety: mechanism, evidence, and dosing protocols.
Ketamine Troches for Depression: Evidence and Protocols
Ketamine troches show significant promise for treatment-resistant depression. Review the clinical evidence, mechanisms of action, treatment protocols, and what to expect from troche-based antidepressant therapy.